Abstract
The human tumour suppressor gene PTEN located at 10q23 is mutated in a variety of tumour types particularly metastatic cases and in the germline of some individuals with Cowdens cancer predisposition syndrome. We have assessed the status of PTEN and associated pathways in cell lines derived from 19 squamous cell carcinomas of the head and neck. Loss of heterozygosity is evident at, or close to the PTEN gene in 5 cases, however there were no mutations in the remaining alleles. Furthermore by Western analysis PTEN protein levels are normal in all of these SCC-HN tumours and cell lines. To assess the possibility that PTEN may be inactivated by another mechanism, we characterized lipid phosphatase levels and from a specific PIP3 biochemical assay it is clear that PTEN is functionally active in all 19 human SCCs. Our data strongly suggest the possibility that a tumour suppressor gene associated with development of SCC-HN, other than PTEN, is located in this chromosomal region. This gene does not appear to be MXI-1, which has been implicated in some other human tumour types. PTEN is an important negative regulator of PI3Kinase, of which subunit alpha is frequently amplified in SCC-HN. To examine the possibility that PI3K is upregulated by amplification in this tumour set we assessed the phosphorylation status of Akt, a downstream target of PI3K. In all cases there is no detectable increase in Akt phosphorylation. Therefore there is no detectable defect in the PI3K pathway in SCC-HN suggesting that the reason for 3q26.3 over-representation may be due to genes other than PI3K110α. © 2001 Cancer Research Campaign http://www.bjcancer.com
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Ali IU, Schriml LM and Dean M (1999) Mutational spectra of PTEN/MMAC1 gene: A tumor suppressor with lipid phosphatase activity. J Nat Cancer Inst 91: 1922–1932
Bockmuhl U, Schmidt S, Peterson S and Peterson I (2000) Deletion of chromosome 10q–a marker for metastasis of head and neck carcinomas? Laringorhinootologie 79: 81–85
Boyd J (1997) Mutaton analysis of the putative tumour supressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res 57: 3657–3659
Chen Q, Samaranayake LP, Zhou H and Xiao L (1999) Homozygous deletion of the PTEN tumor suppressor gene is not a feature in oral squamous cell carcinoma. Oral Oncology 36: 95–99
Cobb MH and Goldsmith EJ (1995). Journal of Biological Chemistry 270: 14843–14846
Edington K, Loughran OP, Berry IJ and Parkinson EK (1995) Cellular immortality: A late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. Mol Carcinog 13: 254–265
Kubo Y, Urano Y, Hida Y and Arase S (1999) Lack of somatic mutation in the PTEN gene in squamous cell carcinoma of human skin. Journal of Dermatological Science 19: 199–201
Ma Y-Y, Wei S-J, Lin Y-C, Lung J-C, Chang T-C, Whengpeng J, Liu JM, Yang D-M, Yang WK and Shen C-Y (2000) P13CA as an oncogene in cervical cancer. Oncogene 19: 2739–2744
Maehama T and Dixon JE (1999) The tumour suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4, 5-trisphosphate. The Journal of Biological Chemistry 273: 13375–13378
Marsh DJ, Kum JB and Lunetta KL (1999) PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Human molecular genetics 8: 1461–1472
Okami K, Wu L, Riggins G, Cairns P, Goggins M, Evron E, Halachmi N, Ahrendt SA, Reed AL, Hilgers W, Kern SE, Koch WM, Sidransky D and Jen J (1998) Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumours. Cancer Research 58: 509–511
Quinn AG, Sikkink S and Rees JL (1994) Basal cell carcinomas and squamous cell carcinomas of human skin show a distinct pattern of chromosome loss. Canc Res 54: 4756–4759
Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI and Boyd J (1997) Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Research 57: 3657–3659
Rheinwald JG and Beckett MA (1981) Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous-cell carcinomas. Cancer research 41: 1657–1663
Risinger JI, Hayes AK, Berchuck A and Barrett JC (1997) PTEN/MMAC1 mutations in endometrial cancers. Cancer Research 57: 4736–4738
Shao X, Tandon R, Samara G, Kanki H, Yano H, Close LG, Parsons R and Sato T (1998) Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma. Int J Canc 77: 684–688
Shayesteh (1999). Nat Genet 21: 99–102
Speicher MR, Howe C, Crotty P, Du Manoir S, Costa J and Ward DC (1995) Comparative genomic hybridisation detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 55: 1010–1013
Tresini M, Mawal-Dewan M, Cristofolo VJ and Sell C (1998). Cancer Res 58: 1–4
Vasquez F and Sellers WR (2000) The PTEN tumour suppressor protein: an antagonist of phosphoinositide signalling. BBA 1470: M21–M35
Whang YE, Wu XY, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB and Sawyers CL (1998) Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proceedings of the National Academy of Sciences of the United states of America, 95, 5246–5250
Yamashita T, Tonoki H, Moriuchi T, Jin HY and Jimbow K (1999) Wild-type p53 induces apoptosis in pigmented melanoma cell lines SK-mel-23 and 70W without altering p21 (Wafl), Bcl-2 and Bax expression. Journal of Investigative Dermatology 112: 701
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Snaddon, J., Parkinson, E., Craft, J. et al. Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus. Br J Cancer 84, 1630–1634 (2001). https://doi.org/10.1054/bjoc.2001.1848
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1848
Keywords
- PTEN
- LOH
- carcinoma
- P13K
This article is cited by
-
PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients
Journal of Cancer Research and Clinical Oncology (2012)
-
Ect2 links the PKCι–Par6α complex to Rac1 activation and cellular transformation
Oncogene (2009)
-
Matrix metalloproteinase-10 is a critical effector of protein kinase Cι-Par6α-mediated lung cancer
Oncogene (2008)
